Results 181 to 190 of about 397,359 (338)
The contact allergy prevalence in individuals with diabetes and in diabetes medical device (MD) users is unknown. This study in 204 diabetes MD users (114 with rash to diabetes MDs, 90 without) aimed at investigating the contact allergy prevalence to baseline series allergens. Contact allergies to sesquiterpene lactone mix and myroxylon pereirae resin (
Thanisorn Sukakul +5 more
wiley +1 more source
Activity and Abundance of Nitrous Oxide Reducing Bacteria in Platismatia glauca: An Epiphytic Lichen in the Boreal Spruce Forest. [PDF]
Abagnale V +5 more
europepmc +1 more source
This case–control study shows that patients with allergic contact dermatitis have a higher burden of psychopathological symptoms than controls, particularly in phobic anxiety and somatization, highlighting the frequent coexistence of psychological distress in allergic contact dermatitis.
Francisco José Navarro‐Triviño +3 more
wiley +1 more source
Different Patterns of Lichen Planus in Three Members of One Family. [PDF]
Abtahi-Naeini B +3 more
europepmc +1 more source
Lichen sclerosus and risk of cancer
P. Halonen +5 more
semanticscholar +1 more source
Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex
Australasian Journal of Dermatology, EarlyView.
Aalia Syed +2 more
wiley +1 more source
Metal Sensitization in Patients That Underwent Patch Test Pre and Post‐Implant Exposure
Sensitization to metals was similar in pre‐implant and post‐implant patients. Women with jewellery allergy are at higher risk to have a patch test positive to metals. Post‐implant testing in case of contact dermatitis could be helpful to identify culprit allergens. ABSTRACT Background Sensitization to metals can cause allergic symptoms in subjects that
Nicholas Zampa +5 more
wiley +1 more source
A comprehensive analysis of online patient educational materials for lichen sclerosus. [PDF]
Foster J, Chang HR, Mauskar MM.
europepmc +1 more source
Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
M. Bleeker +4 more
semanticscholar +1 more source
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina +5 more
wiley +1 more source

